Cervical metastases of squamous cell carcinoma of the maxilla: a retrospective study of 9 years by Kruse, Astrid LD & Grätz, Klaus W
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
Head & Neck Oncology
Open Access Research
Cervical metastases of squamous cell carcinoma of the maxilla: a 
retrospective study of 9 years
Astrid LD Kruse* and Klaus W Grätz
Address: Department of Craniomaxillofacial and Oral Surgery, University of Zurich, Switzerland
Email: Astrid LD Kruse* - astridkruse@gmx.ch; Klaus W Grätz - klaus.graetz@zzmk.uzh.ch
* Corresponding author    
Abstract
Purpose: Metastases of squamous cell carcinoma of the tongue and the mouth floor have been
well studied. Concerning maxilla squamous cell carcinomas, however, only a few studies have been
performed. The question is whether a prophylactic neck dissection should be performed in these
tumors.
Patients and Material: In the Department of Craniomaxillofacial Surgery at the University
Hospital of Zurich, 30 patients who had been treated for squamous cell carcinonoma of the maxilla
were examined retrospectively. Special attention was paid to direct and late metastasis, survival
rate, and treatment.
Results: Of the 59 patients with upper jaw carcinomas over a 9-year period, only about half (30
patients) had a squamous cell carcinoma of the upper jaw. Of those patients, 27% had an upper
lesion on the right side, 33% on the left. Of the 11 patients (36.7%) presenting positive lymph nodes,
4 patients had direct positive lymph nodes while 7 patients had later positive lymph nodes; and
71.4% of the late metastasis appeared during the first year.
Conclusion: Because of the 36.7% of patients presenting metastases in the cervical lymph nodes,
elective neck treatment should be considered in cases even with a negative clinical examination.
Introduction
The estimated number of European patients with newly
diagnosed cancers of the oral cavity and pharynx is 97,800
per year, and the estimated number of deaths because of
these carcinomas is 40,100 in Europe per year. The world-
wide incidence of oropharyngeal cancer is 8.3 cases per
100.000 [1]. Squamous cell carcinoma is the most com-
mon type of tumor among cancers in the oral cavity. These
tumors metastasize, usually through the lymphatic sys-
tem, to cervical lymph nodes in levels I and II [2,3]. Sev-
eral studies have been done on the metastasis of
squamous cell carcinoma of the tongue/mouth floor and,
in particular, on prophylactic neck dissection for tongue
cancer [4]. It is well documented that patients with nega-
tive cervical lymph nodes have a good prognosis, but if
lymph node metastasis occurs after excision of the pri-
mary tumor, the prognosis is poor.
Only a few investigations have been done into the metas-
tasis of squamous cell carcinoma of the upper jaw. But it
is striking that the incidence of cervical lymph node
metastasis from cancer of the maxilla is significant [5].
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Therefore, this retrospective study will present data con-
cerning the proportion of metastasis in squamous cell car-
cinomas of the upper jaw.
Methods
Between January 1999 and July 2007, 59 patients with a
malignant tumor of the upper jaw were referred to the
Department of Cranio-Maxillofacial Surgery at the Uni-
versity Hospital of Zurich; of these, 30 patients had a
squamous cell carcinoma of the upper jaw.
The female-male rate was 17:13, and the mean age of the
first diagnosis was 73.1 years (in an age range of 32 – 91
years). All were staged by using the system of the Interna-
tional Union Against Cancer [6]. Pathohistological grad-
ing was also considered.
Results
A great number of the upper jaw tumors were found in the
upper alveolar ridge (33% on the left, 27% on the right)
(Fig. 1).
Out of 30 patients with squamous cell carcinoma of the
upper jaw, 11 patients (36.7%) presented positive lymph
nodes, with direct positive lymph nodes in 4 patients and
later positive lymph nodes in 7 patients (Fig. 2).
The correlation between pathological T-status and the
occurrence of metastatic lymph nodes is presented in fig
3. Of patients with positive lymph nodes, 5 were found in
T1-tumors and 5 in T2-tumors (Fig. 3)
Indications for neck dissection were clinical involvement
of the cervical lymph nodes and suspect cervical lymph
nodes as a result of a Ct, MRI, or PET/Ct scan.
A supraomohyoidal neck dissection was performed on 2
patients because of suspect lymph nodes in a CT-scan,
MRI, or PET, but the pathohistological exam revealed no
positive lymph nodes in these cases. However, no metas-
tasis has been revealed in these 2 patients up to now.
The most common pattern for positive cervical lymph
nodes was in the present study at T1 G2 and T2 G2 status.
In cases of late metastasis, 71.4% appeared during the first
year (Fig. 4).
Of the 30 patients, 9 are dead of disease (Fig. 5). The 4
patients with direct positive lymph nodes are all alive,
while 4 out of the 7 patients with late positive lymph
nodes are deceased.
Discussion
Clinicopathologic factors associated with the develop-
ment of cervical lymph node metastasis have been well
studied for other locations like tongue, mouth floor, and
cheek, in particular concerning tumor size (in tongue car-
cinoma ≥3 mm), tumor depth (≥4 mm in tongue carci-
Distribution of localizations in the upper jaw Figure 1
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noma), differentiation, mode of invasion, microvascular
invasion, and histologic grade of malignancy [7-9]. The
presence or absence of lymph node metastasis is one
major prognostic factor for survival in patients with nega-
tive cervical lymph nodes [10]. A high incidence (20–
30%) of cervical metastasis of cancer in the tongue/mouth
floor has been well studied [7-9]. But very few studies
have been performed concerning squamous cell carci-
noma of the maxilla [5].
The results in the present study reveal that the higher the
grading, the higher the risk of cervical metastasis. These
results correlate with those of Sparamo et al [8] (2004) for
tongue cancer.
Simental et al. (2006) [5] found cervical metastasis from
squamous cell carcinoma of the maxillary alveolus and
hard palate in 34.6% of patients. In the present study the
portion of patients with cervical metastasis was similiar
(33.6%).
Haddadin et al. (1998) [4], Kligerman et al. (1994) [11]
and Capote et al. (2006) [12] found that patients with
clinical T1/T2 tongue cancer who underwent a synchro-
nous neck dissection had an improved survival outcome.
Also O'Brien et al. (2000) [13] found occult metastatic
disease in 30% of patients, and Lim et al. (2006) [14-16]
found it in 28%. Therefore, regarding the proportion of
late cervical metastasis, the question arises whether an
elective neck dissection should be provided in early-stage
squamous cell carcinoma. Capote et al. (2006) [12]
reported that in pT1N0 and pT2N0 oral squamous cell
carcinoma, neck dissection therapy was a significant prog-
nostic factor for recurrence and survival. Therefore tumor
size, tumor depth, and differentiation should be taken
into consideration for the planning of neck dissection for
squamous cell carcinoma of the upper jaw. Also the mode
of invasion plays an important role in therapy planning
because in certain localizations like the palate, the tumor
does not need to invade very deeply before reaching the
bone. In the current study, it was surprising that only 6
patients revealed a T4 status.
Another problem that should be considered seems to be
the detection of micrometastasis. The assessment of the
status of cervical lymph nodes is difficult, and therefore a
treatment of patients with a clinical stage N0 neck is con-
troversial. In most studies the use of CT has an error rate
ranging from 7.5 to 19% [17].
Distribution of patients with lymph node status Figure 2
Distribution of patients with lymph node status.
Distribution of tumor size and grading Figure 3
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In the late 1990s the positron emission tomography (PET)
using F-18 fluorodecyglucose (FDG), a functional imag-
ing methodology that provides information about tissue
glucose metabolism, was applied. PET consequently a
high FDG accumulation is manifested on PET images, but
inflammation also reveals an increased FDG uptake and
can lead to false-positive results. On the other hand, low
tumor metabolic activity, the presence of small lesions,
and hypoglycemia can lead to false-negative results [18].
Concerning cervical lymph nodes, Ng et al. (2005) [19]
reported that sensitivity and specificity of PET images were
75% and 93%, respectively. Sigg et al. (2003) [20]
reported a sensitivity of 93% and a specificity of 100%.
PET together with CT images showed a 15% increase in
the accurate identification of nodal staging over using the
PET images alone [21]. PET/CT seems to have a higher
sensitivity and specificity for detecting lymph node metas-
tasis [21,22]. In the last time the role of sentinel lymph
node biopsies is discussed [23].
It is possible that prognostic markers – e.g., p53, CD44,
cyclin D1 gene, and epidermal growth factor receptors for
occult cervical lymph node metastasis that have been
studied [24,25] – can help to optimize the treatment in
patients with upper jaw cancer and occult metastatic
lymph nodes.
The main limitation of this study was the low number of
patients and the lack of carcinomas arising from the max-
illary sinus. But considering the limitations of this study,
multicenter studies should be performed in order to
develop evidence-based protocols for treatment of squa-
mous cell carcinomas of the maxilla.
Conclusion
Because of the 36.7% of the patients presenting metas-
tases in the cervical lymph nodes from squamous cell car-
cinoma of the upper jaw, elective neck treatment should
be considered even in cases with a negative clinical exam-
ination.
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